The need for a next-generation public health response to rare diseases
- PMID: 27787501
- PMCID: PMC5547019
- DOI: 10.1038/gim.2016.166
The need for a next-generation public health response to rare diseases
Conflict of interest statement
The authors declare no conflict of interest.
Comment on
-
The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort.Genet Med. 2017 May;19(5):546-552. doi: 10.1038/gim.2016.143. Epub 2016 Sep 22. Genet Med. 2017. PMID: 27657686 Free PMC article.
References
-
- Institute for Health Metrics and Evaluation. The Global Burden of Disease: Generating Evidence, Guiding Policy. IHME; Seattle, WA: 2013.
-
- de Vrueh R, Baekelandt ERF, de Haan JMH. Priority medicines for Europe and the world: a public health approach to innovation. WHO Background Paper 6.19. Rare Diseases. 2013 http://www.who.int/medicines/areas/priority_medicines/BP6_19Rare.pdf. Accessed 16 August 2016.
-
- Orphanet. ICD-10 coding rules for rare diseases. Orphanet procedural document. 2014 Oct; http://www.orpha.net/orphacom/cahiers/docs/GB/Orphanet_ICD10_coding_rule.... Accessed 17 October 2016.
-
- Yoon PW, Olney RS, Khoury MJ, Sappenfield WM, Chavez GF, Taylor D. Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study. Arch Pediatr Adolesc Med. 1997;151:1096–1103. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
